Literature DB >> 19386699

Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads.

Yu-Wen Lin1, Kung-Chao Chang, Chia-Min Kao, Shih-Ping Chang, Yuk-Ying Tung, Shun-Hua Chen.   

Abstract

Enterovirus 71 (EV71) infects the central nervous system and causes death and long-term neurological sequelae in hundreds of thousands of young children, but its pathogenesis remains elusive. Immunopathological mechanisms have been suspected to contribute to the pathogenesis of neurological symptoms, so anti-inflammatory agents have been used to treat patients with neurological symptoms. The present study was therefore designed to investigate the functions of lymphocyte and antibody responses in EV71 infection using a mouse model. Immunohistochemical staining analysis revealed virus and three types of lymphocytes, B cells, CD4 T cells, and CD8 T cells, in the spinal cord of an EV71-infected patient who died. A study of mice showed that the levels of virus and lymphocytes in brains and antibody titers in sera were elevated during the time when the mice succumbed to death in a phenomenon analogous to that observed in patients. Further studies demonstrated that after infection, the disease severity, mortality, and tissue viral loads of mice deficient in B, CD4 T, or CD8 T cells were significantly higher than those of wild-type mice. In addition, treatment with a virus-specific antibody, but not a control antibody, before or after infection significantly reduced the disease severity, mortality, and tissue viral loads of mice deficient in B cells. Our results show that both lymphocyte and antibody responses protect mice from EV71 infection. Our study suggests the use of vaccines and virus-specific antibodies to control fatal outbreaks and raises caution over the use of corticosteroids to treat EV71-infected patients with neurological symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386699      PMCID: PMC2698549          DOI: 10.1128/JVI.00434-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus.

Authors:  C N Wu; Y C Lin; C Fann; N S Liao; S R Shih; M S Ho
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

2.  An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis.

Authors:  J J Yan; J R Wang; C C Liu; H B Yang; I J Su
Journal:  J Clin Virol       Date:  2000-06       Impact factor: 3.168

3.  Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice.

Authors:  C K Yu; C C Chen; C L Chen; J R Wang; C C Liu; J J Yan; I J Su
Journal:  J Biomed Sci       Date:  2000 Nov-Dec       Impact factor: 8.410

4.  Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia.

Authors:  P McMinn; I Stratov; L Nagarajan; S Davis
Journal:  Clin Infect Dis       Date:  2000-12-28       Impact factor: 9.079

5.  A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection.

Authors:  Ya-Fang Wang; Chun-Ting Chou; Huan-Yao Lei; Ching-Chuan Liu; Shih-Min Wang; Jing-Jou Yan; Ih-Jen Su; Jen-Reng Wang; Trai-Ming Yeh; Shun-Hua Chen; Chun-Keung Yu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002.

Authors:  Luan-Yin Chang; Shao-Hsuan Hsia; Chang-Teng Wu; Yhu-Chering Huang; Kuang-Lin Lin; Tsui-Yen Fang; Tzou-Yien Lin
Journal:  Pediatr Infect Dis J       Date:  2004-04       Impact factor: 2.129

7.  Survival after pulmonary edema due to enterovirus 71 encephalitis.

Authors:  M A Nolan; M E Craig; M M Lahra; W D Rawlinson; P C Prager; G D Williams; A M E Bye; P I Andrews
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

8.  Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema.

Authors:  Shih-Min Wang; Huan-Yao Lei; Kao-Jean Huang; Jing-Ming Wu; Jen-Ren Wang; Chun-Keung Yu; Ih-Jen Su; Ching-Chuan Liu
Journal:  J Infect Dis       Date:  2003-07-23       Impact factor: 5.226

9.  Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro.

Authors:  Tzou-Yien Lin; Chishih Chu; Cheng-Hsun Chiu
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

10.  Enterovirus 71 infection: a new threat to global public health?

Authors:  Jane Qiu
Journal:  Lancet Neurol       Date:  2008-10       Impact factor: 44.182

View more
  43 in total

1.  Analysis of the Th1/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys.

Authors:  Yan Liang; Xiaofang Zhou; Erxia Yang; Jing Pu; Yanchun Che; Jingjing Wang; Na Ma; Longding Liu; Dong Ding; Donghong Tang; Dong Sheng; Lixian Yang; Hongling Zhao; Chenghong Dong; Qihan Li
Journal:  J Clin Immunol       Date:  2012-05-15       Impact factor: 8.317

2.  Coxsackievirus A16 infection stimulates imbalances of T cells in children.

Authors:  Qingming Luo; Wanjun Peng; L I Chen
Journal:  Exp Ther Med       Date:  2015-04-03       Impact factor: 2.447

3.  An elaborate landscape of the human antibody repertoire against enterovirus 71 infection is revealed by phage display screening and deep sequencing.

Authors:  Zhe Chen; Xianwen Ren; Jian Yang; Jie Dong; Ying Xue; Lilian Sun; Yafang Zhu; Qi Jin
Journal:  MAbs       Date:  2016-12-08       Impact factor: 5.857

4.  Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice.

Authors:  Juhao Yang; Chunfu Yang; Nining Guo; Kai Zhu; Kaiming Luo; Na Zhang; Hui Zhao; Ying Cui; Lei Chen; Hongyang Wang; Jun Gu; Baoxue Ge; Cheng-Feng Qin; Qibin Leng
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

5.  Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.

Authors:  Yanyan Ke; Wai Nam Liu; Zhisheng Her; Min Liu; Sue Yee Tan; Yong Wah Tan; Xue Ying Chan; Yong Fan; Edwin Kunxiang Huang; Huiyi Chen; Kenneth Tou En Chang; Jerry Kok Yen Chan; Justin Jang Hann Chu; Qingfeng Chen
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

6.  Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation.

Authors:  Li-Chiu Wang; Su-O Chen; Shih-Ping Chang; Yi-Ping Lee; Chun-Keung Yu; Chia-Ling Chen; Po-Chun Tseng; Chia-Yuan Hsieh; Shun-Hua Chen; Chiou-Feng Lin
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 7.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

8.  The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.

Authors:  Chun Shi Jia; Jiang Ning Liu; Wan Bo Li; Chun Mei Ma; Shu Zhu Lin; Yi Hao; Xue Zhong Gao; Xiao Lin Liu; Yan Feng Xu; Lian Feng Zhang; Chuan Qin
Journal:  Virol J       Date:  2010-02-22       Impact factor: 4.099

9.  Clinical Features and Peripheral Blood T Lymphocyte Subsets in Hand, Foot, and Mouth Disease According to Different Pathogens.

Authors:  Jian-Fang Zhou; Zhi-Yong Chen; Shan-Ming Yang; Jia-Zhen Chen; Ling-Ye Zhou; Ya-Fen Wang; Gang Wang; Xia-Jian Yu; Wen-Hong Zhang
Journal:  Indian J Pediatr       Date:  2016-07-28       Impact factor: 1.967

10.  Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection.

Authors:  Hsiang-Yin Lin; Ya-Ting Yang; Shu-Ling Yu; Kuang-Nan Hsiao; Chia-Chyi Liu; Charles Sia; Yen-Hung Chow
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.